Lucy S. Witt, MD, MPH

Emory University

Disclosure(s): Merck & Co: Grant/Research Support

Poster(s):

• (P-12) Impact of Development and Implementation of System Wide Guidelines on Management of Uncomplicated Gram-Negative Bacteremia at a Community Hospital
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-544) Respiratory and Nonrespiratory Complications in Children Hospitalized with Influenza in the Post-2009 H1N1 Pandemic Era
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-625) Deaths Associated with Laboratory-confirmed COVID-19-associated Hospitalizations, Including In-hospital and Post-discharge Deaths, COVID-NET, March 2020 – September 2023
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-675) Chronic Conditions as Risk Factors for Respiratory Syncytial Virus-Associated Hospitalization among Community-Dwelling Adults Aged 18-49 Years, 2016-2017 and 2017-2018 Seasons
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-782) Developing a Multivariable Prediction Model of Antibiotic Heteroresistance to First-Line Therapies for Urinary Tract Infection
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-992) Impact of Ertapenem De-restriction on Hospital Length of Stay for ESBL-producing Enterobacterales Bloodstream Infections
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-2020) Community Acquired Pneumonia Dashboard: An Antimicrobial Stewardship Solution to Treatment Guidance Adherence Monitoring
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET